NNNN (Anbio Biotechnology) Total Operating Expense: $1.78 Mil (TTM As of Dec. 2025)


NNNN Anbio Biotechnology NNNN
24 GF Score
Price $12.20
! 2 Warning Signs
View Full Analysis

What is Anbio Biotechnology Total Operating Expense?

Anbio Biotechnology NNNN +3.92% 24 Total Operating Expense is $1.78 Mil as of Dec. 2025. GuruFocus rates NNNN with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

Anbio Biotechnology's Total Operating Expense for the six months ended in Dec. 2025 was $0.91 Mil. Anbio Biotechnology's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $1.78 Mil.

Anbio Biotechnology Total Operating Expense Related Terms

Anbio Biotechnology Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Anbio Biotechnology's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anbio Biotechnology Total Operating Expense Chart

Anbio Biotechnology Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
0.09 2.37 1.40 3.89 1.78

Anbio Biotechnology Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only 1.02 0.31 3.58 0.87 0.91
NNNN
24GF Score
Anbio Biotechnology NNNN
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anbio Biotechnology Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1.78 Mil mean?
Anbio Biotechnology (NNNN) has a Total Operating Expense of $1.78 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Anbio Biotechnology and its competitors.
Is Anbio Biotechnology's Total Operating Expense too high?
Anbio Biotechnology's current Total Operating Expense is $1.78 Mil. Overall, Anbio Biotechnology has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Anbio Biotechnology's Total Operating Expense compare to ANGO and OSUR?
Anbio Biotechnology's Total Operating Expense of $1.78 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Anbio Biotechnology and its competitors. Anbio Biotechnology's current Total Operating Expense is $1.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anbio Biotechnology stock overvalued right now?
Anbio Biotechnology (NNNN) has a current Total Operating Expense of $1.78 Mil. The current Total Operating Expense is $1.78 Mil. Anbio Biotechnology's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Anbio Biotechnology (NNNN), the current Total Operating Expense is $1.78 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anbio Biotechnology Business Description

Address Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, HE, DEU, 60327
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
24GF Score

Get the complete analysis for NNNN

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.20
Price